News & Updates

The latest developments across the GLP-1 landscape, from new drug approvals and clinical research to pricing changes and policy shifts. Stay informed on the updates that affect Ozempic, Wegovy, Mounjaro, and the wider category.

News & Updates

India Approves Wegovy for Fatty Liver Disease

India has approved Wegovy for the treatment of fatty liver disease, marking a significant expansion of semaglutide's approved uses. This follows growing clinical evidence that GLP-1 medications can reduce liver fat and inflammation. Here's what patients need to know.

News & Updates

India's Ozempic Generic Coming to South Africa

An Indian pharmaceutical company is preparing to launch a generic version of semaglutide, the active ingredient in Ozempic, in South Africa. This could mark a turning point for GLP-1 access in emerging markets. Here is what patients and providers should understand about what is coming.

News & Updates

BI 3034701: Triple Receptor Obesity Drug Enters Phase II

Boehringer Ingelheim has moved its investigational triple receptor agonist BI 3034701 into Phase II clinical trials, targeting GLP-1, GIP, and NPY2 receptors simultaneously. This makes it a potential first-in-class treatment that goes beyond current dual-receptor drugs like tirzepatide. Here's what patients should know about this development and what it means for the future of obesity treatment.

News & Updates

Why Everyone Is Googling GLP-1 Drugs Right Now

Online searches for weight-loss medications have exploded 25-fold since GLP-1 drugs like Ozempic and Wegovy entered the market. This surge reflects real demand, but it also means more confusion and misinformation. Here's how to cut through the noise and find information that actually helps you.

News & Updates

Foundayo: The New Oral GLP-1 Weight Loss Pill

Foundayo is a newly approved oral GLP-1 medication that offers a pill-based alternative to injectable weight loss drugs like Wegovy and Ozempic. This guide covers how it works, who it is for, what it costs, and the key questions to ask your doctor before switching or starting treatment.

News & Updates

Diet Coke for Bezoars: What Ozempic Users Need to Know

A woman on Ozempic developed a hardened mass in her stomach called a bezoar, and doctors dissolved it with 1.5 liters of Diet Coke. This unusual case highlights a real but underreported risk for GLP-1 users: slowed stomach emptying. Here's what patients should know.

News & Updates

Medicare GLP-1 Bridge Program: What It Means for You

Medicare's GLP-1 bridge program is pushing to expand access to semaglutide and tirzepatide for eligible beneficiaries. Here's what the program covers, who qualifies, and how to prepare if you're currently paying out of pocket for these medications.

News & Updates

CMS GLP-1 Obesity Pilot: What It Means for You

The Centers for Medicare and Medicaid Services is piloting coverage for GLP-1 medications used to treat obesity. This article breaks down what the pilot actually involves, what critics are questioning, and what it could mean for your out-of-pocket costs and access to medications like Wegovy and Zepbound.